Piceatannol, a resveratrol analog, effectively protects against CCl4-induced liver fibrosis in mice by improving liver function, reducing collagen deposition, and suppressing fibrosis markers via the TGF-β/Smad pathway. Here, TGFB1 is linked to Hepatic fibrosis.